Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20160
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Roukos, D. H. | en |
dc.date.accessioned | 2015-11-24T19:05:13Z | - |
dc.date.available | 2015-11-24T19:05:13Z | - |
dc.identifier.issn | 1744-8352 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20160 | - |
dc.rights | Default Licence | - |
dc.subject | Antineoplastic Agents/*therapeutic use | en |
dc.subject | Biomedical Research | en |
dc.subject | Clinical Trials as Topic | en |
dc.subject | Drug Approval | en |
dc.subject | *Drug Design | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Neoplasms/*therapy | en |
dc.subject | Proto-Oncogene Proteins/genetics | en |
dc.subject | Proto-Oncogene Proteins B-raf/genetics | en |
dc.subject | Receptor, Epidermal Growth Factor/antagonists & inhibitors | en |
dc.subject | ras Proteins/genetics | en |
dc.title | Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.1586/erm.09.7 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19379079 | - |
heal.identifier.secondary | http://www.expert-reviews.com/doi/pdfplus/10.1586/erm.09.7 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2009 | - |
heal.journalName | Expert Rev Mol Diagn | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Roukos-2009-Mea Culpa with cance.pdf | 633.49 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License